Patents by Inventor Mary Ann Pfannenstiel

Mary Ann Pfannenstiel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibiotic-free compositions for the prevention or control of coccidiosis
    Patent number: 11692164
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: July 4, 2023
    Assignee: Huvepharma Inc.
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht, Glen M. Wilkinson
  • ANTIBIOTIC-FREE COMPOSITIONS FOR THE PREVENTION OR CONTROL OF COCCIDIOSIS
    Publication number: 20210332322
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht, Glen M. Wilkinson
  • Adjuvant compositions and related methods
    Patent number: 11154604
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: October 26, 2021
    Assignee: Huvepharma, Inc.
    Inventors: Timothy J. Miller, Mary Ann Pfannenstiel
  • ANTIBIOTIC-FREE COMPOSITIONS FOR THE PREVENTION OR CONTROL OF COCCIDIOSIS
    Publication number: 20200370003
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Application
    Filed: May 7, 2020
    Publication date: November 26, 2020
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht, Glen M. Wilkinson
  • Antibiotic-free compositions for the prevention or control of coccidiosis
    Patent number: 10781418
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: September 22, 2020
    Assignee: HUVEPHARMA, INC.
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht, Glen M. Wilkinson
  • ANTIBIOTIC-FREE COMPOSITIONS FOR THE PREVENTION OR CONTROL OF COCCIDIOSIS
    Publication number: 20190382712
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Application
    Filed: August 26, 2019
    Publication date: December 19, 2019
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht, Glen M. Wilkinson
  • ADJUVANT COMPOSITIONS AND RELATED METHODS
    Publication number: 20190167777
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Application
    Filed: February 4, 2019
    Publication date: June 6, 2019
    Inventors: Timothy J. Miller, Mary Ann Pfannenstiel
  • Adjuvant compositions and related methods
    Patent number: 10265395
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and a DNA component. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: April 23, 2019
    Inventors: Timothy J Miller, Mary Ann Pfannenstiel
  • Adjuvant compositions and related methods
    Patent number: 10195261
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Grant
    Filed: November 27, 2015
    Date of Patent: February 5, 2019
    Assignee: VaxLiant, LLC
    Inventors: Timothy J Miller, Mary Ann Pfannenstiel
  • ANTIBIOTIC-FREE COMPOSITIONS FOR THE PREVENTION OR CONTROL OF COCCIDIOSIS
    Publication number: 20180208885
    Abstract: Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.
    Type: Application
    Filed: January 24, 2017
    Publication date: July 26, 2018
    Inventors: Mary Ann Pfannenstiel, Jennifer Albrecht
  • ADJUVANT COMPOSITIONS AND RELATED METHODS
    Publication number: 20170202959
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and a DNA component. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 20, 2017
    Inventors: Timothy J Miller, Mary Ann Pfannenstiel
  • Adjuvant compositions and related methods
    Patent number: 9636397
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and a DNA component. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: May 2, 2017
    Assignee: Vaxliant, LLC
    Inventors: Timothy J Miller, Mary Ann Pfannenstiel
  • ADJUVANT COMPOSITIONS AND RELATED METHODS
    Publication number: 20160279237
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and a DNA component. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Application
    Filed: March 24, 2016
    Publication date: September 29, 2016
    Inventors: Timothy J. Miller, Mary Ann Pfannenstiel
  • ADJUVANT COMPOSITIONS AND RELATED METHODS
    Publication number: 20160144037
    Abstract: The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
    Type: Application
    Filed: November 27, 2015
    Publication date: May 26, 2016
    Inventors: Timothy J Miller, Mary Ann Pfannenstiel
  • Methods and compositions for the control of coccidiosis
    Patent number: 7846685
    Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: December 7, 2010
    Assignee: Novus International, Inc.
    Inventors: Charles S. Schasteen, Jackie Green, Lance Bull, Farooq Uraizee, Mary Ann Pfannenstiel, Tony Allington, Steven J. Mueller
  • Methods and compositions for the control of coccidiosis
    Publication number: 20040175391
    Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.
    Type: Application
    Filed: March 12, 2004
    Publication date: September 9, 2004
    Applicant: Novus International, Inc.
    Inventors: Charles S. Schasteen, Jackie Green, Lance Bull, Farooq Uraizee, Mary Ann Pfannenstiel, Tony Allington, Steven J. Mueller
  • Identification and enumeration of coccidial sporocysts
    Publication number: 20020182663
    Abstract: A method for the identification and enumeration by flow cytometry of species of coccidial sporocysts and in particular sporocysts of the genus Eimeria is disclosed. The method is useful in the identification and enumeration of coccidial protozoa in environmental samples, designing treatment programs for animals infected with coccidial protozoa, and for quality control of preparations containing coccidial protozoa.
    Type: Application
    Filed: March 27, 2002
    Publication date: December 5, 2002
    Applicant: Novus International, Inc.
    Inventor: Mary Ann Pfannenstiel
  • Methods and compositions for the control of coccidiosis
    Publication number: 20020160022
    Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.
    Type: Application
    Filed: November 8, 2001
    Publication date: October 31, 2002
    Inventors: Charles S. Schasteen, Jackie Green, Farooq Uraizee, Lance Bull, Mary Ann Pfannenstiel, Tony Allington
  • Viability assay for sporocyst-forming protozoa
    Patent number: 6344340
    Abstract: A method is disclosed for determining the viability of sporocyst-forming protozoa. The method involves treating a sample of protozoa with at least one vital dye and determining the viability of the protozoa in the sample by differential staining. The viability of protozoa in the sample can then be correlated with the viability of protozoa in the population from which the sample was obtained.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: February 5, 2002
    Assignee: Novus International, Inc.
    Inventors: Julia Dibner, Marianne L. Kitchell, Mary Ann Pfannenstiel